Skip to main content
Psychedelic State(s) of America
Subscribe
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices

NEWS · COMMENTARY · ANALYSIS · EDUCATION

Psychedelic State(s) of America

Psychedelic State(s) of America is dedicated to empowering rigorously independent psychedelic news, commentary, analysis, and education across the United States and around the world.

Read the latestExplore the map

Your PSA

Your follows

Reporting as Seen in, Cited, and Featured By

  • Forbes Magazine logo
  • GBH News Boston logo
  • NBC4 Washington logo
  • The Boston Globe logo
  • Boston Institute for Nonprofit Journalism logo
  • TJM Boston logo
  • DoubleBlind Magazine logo
  • PT Media & Podcast logo
  • MM Policy News logo
  • Psychedelic Alpha logo
  • Lucid News logo
  • CTT Magazine logo
  • TD Policy logo
  • Hyphae Leaks logo
  • The Mycopreneur Podcast logo
  • Psy Guide logo
  • The Microdose logo
  • Tricycle Day logo
¿Hablas español?Visita PSA en español

Latest psychedelic news

News and commentary, newest first. Page 1 of 47.

All newsAll commentary
Psychedelic Lawfare cover: Vol. 1, The Singularism Case
Commentary10 min read

Psychedelic Lawfare, Vol. I - "Jensen v. Utah County, from the District of Utah to the Tenth Circuit "

A closer look at and comprehensive legal analysis of "The Singularism Case: Jensen vs. Utah County" - powered by The Psychedelic Bar Association

Ron McNutt
Politics: Senate Releases FY 2027 Psychedelic Directives as ARPA-H Selects Mark Cuban's Cost Plus for Ibogaine Development, under the PSA neon-switch logo with a line drawing of the U.S. Capitol
Politics5 min read

Senate Releases FY 2027 Psychedelic Directives as ARPA-H Selects Mark Cuban's Cost Plus for Ibogaine Development

Appropriators mandate agency action on novel therapies and maintain hemp restrictions without new congressional funding, while HHS awards up to $4.9 million for domestic ibogaine development.

Jack Gorsline
PSA's Regulatory Dispatch, Vol. IV: FDA Opens an Alzheimer’s Prevention Program Without a Rulebook
Commentary11 min read

FDA Opens an Alzheimer’s Prevention Program Without a Rulebook - PSA's Regulatory Dispatch, Vol. IV

The FDA has opened a desk for Alzheimer's prevention without finishing the rulebook that would say what counts as proof a prevention drug worked.

Odette Hauke
Psilocybin mushroom beside a marijuana leaf
Politics3 min read

DEA Boosts Psychedelic Production Quotas For 2027 While Previewing Separate Marijuana Proposal Under Rescheduling

The DEA proposes sharp 2027 increases in legal MDMA, ibogaine and psilocybin production, while holding Schedule I marijuana quotas flat pending a separate rescheduling notice.

Tom Angell
Psychedelic State(s) of America Weekly Policy Briefing cover: outline map of the United States
Politics8 min read

“FDA answers lawmakers on psychedelic trials” – Weekly Psychedelic Policy Briefing: November 10, 2026

FDA answers lawmakers on psychedelic trials, DEA boosts MDMA and ibogaine quotas, Massachusetts waives doctor mandates for veterans, and DEA stay lifts

Jack Gorsline
"With Psilocybin Doses Projected Up to $22,000, Usona and Compass Race Toward FDA Approval" - PSA's Sunday Sound-Off: November 8, 2026
Commentary9 min read

"With Psilocybin Doses Projected Up to $22,000, Usona and Compass Race Toward FDA Approval" - PSA's Sunday Sound-Off: November 8, 2026

Plus: ICYMI - PSA's New Market Directory, and the PSA NewsWire Highlights of the Week!

Jack Gorsline

Commentary

Opinions and analysis from the PSA network. Page 1 of 22.

All op-eds
Psychedelic Lawfare cover: Vol. 1, The Singularism Case
Commentary10 min read

Psychedelic Lawfare, Vol. I - "Jensen v. Utah County, from the District of Utah to the Tenth Circuit "

A closer look at and comprehensive legal analysis of "The Singularism Case: Jensen vs. Utah County" - powered by The Psychedelic Bar Association

Ron McNutt
PSA's Regulatory Dispatch, Vol. IV: FDA Opens an Alzheimer’s Prevention Program Without a Rulebook
Commentary11 min read

FDA Opens an Alzheimer’s Prevention Program Without a Rulebook - PSA's Regulatory Dispatch, Vol. IV

The FDA has opened a desk for Alzheimer's prevention without finishing the rulebook that would say what counts as proof a prevention drug worked.

Odette Hauke
"With Psilocybin Doses Projected Up to $22,000, Usona and Compass Race Toward FDA Approval" - PSA's Sunday Sound-Off: November 8, 2026
Commentary9 min read

"With Psilocybin Doses Projected Up to $22,000, Usona and Compass Race Toward FDA Approval" - PSA's Sunday Sound-Off: November 8, 2026

Plus: ICYMI - PSA's New Market Directory, and the PSA NewsWire Highlights of the Week!

Jack Gorsline
Trauma Doesn’t Follow Funding Cycles
Commentary8 min read

Trauma Doesn’t Follow Funding Cycles

When funding disappears, a harm reduction programme does not simply lose a budget line. It loses people I know by name.

Baby Virgarose Nurmaya

PSA Newswire

See the full PSA Newswire

Upcoming psychedelic events

See the full calendar

Watch the Latest

Watch

PSA’s Global Drug Policy Tracker

Open the tracker

From the Drug Policy Tracker

All timelines

Subscribe to Psychedelic State(s) of America

Subscribe

Popular from PSA

Full archive